Navigation Links
Novavax Reports Second Quarter 2009 Financial Results
Date:8/7/2009

mational," said Novavax Chief Executive Officer, Dr. Rahul Singhvi. "We eliminated 100% of our $22 million outstanding convertible debt and raised net proceeds of $21.9 million through the sale of additional shares under our ATM program. Today, Novavax has a healthy balance sheet with no long term debt and cash and short-term investments of $37.6 million as of July 31, 2009. With this financial strength, we are well positioned to advance our vaccine development programs, and in particular, continue our work on a VLP vaccine candidate against the 2009 pandemic H1N1 strain, so that we are ready to serve public health authorities in the U.S. as well as in foreign countries."

The anticipated milestones for the remainder of 2009 include:

  • Release top-line results from the Phase II trial in healthy adults with our trivalent seasonal flu vaccine candidate;
  • Initiate a Phase II clinical study of our trivalent seasonal flu vaccine in older adults;
  • Continue development of our pandemic H1N1 vaccine candidate;
  • Complete definitive license and supply agreements with ROVI; and
  • Continue expansion of operations at CPL Biologicals.

2009 Financial Results

Revenue from continuing operations for the second quarter ended June 30, 2009 was $29,000, compared to $0.3 million for the same period in 2008, a decrease of $0.3 million due to the completion of two contracts in 2009.

Research and development costs were $5.3 million for the second quarter of 2009 compared to $5.4 million in the second quarter of 2008, a decrease of $0.1 million. The decrease was due to a $0.2 million decrease in employee costs, partially offset by a $0.1 million increase in outside testing costs associated with continuing clinical trials, preclinical testing, process development, manufacturing and quality related programs.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
2. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
3. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
4. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
5. Novavax Announces Repayment of $5 Million of Convertible Debt
6. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
7. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
8. Novavax Appoints Stanley Erck to Board of Directors
9. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
10. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009
11. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) today announced ... funding to support the ongoing development of new ... Association (MDA). This grant will support the ... manufacture of a drug candidate for human clinical ... provides important funding for Repligen,s research but it ...
(Date:12/15/2009)... (AFM) have been developed and are opening up a new ... The NeedleProbes’ cylindrical geometry enables researchers to measure surface tension, ... in a single force distance curve. , ... ... NeedleProbes are enabling unique measurements at the liquid/air ...
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
(Date:12/14/2009)... International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced today ... Scripps Research Institute ("Scripps") by entering into an ... Dyadic,s patented and proprietary C1 fungus ("C1"). ,, ... relationship between the two organizations which began in ... the C1 genome for the first time. The ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5
... Simcere Pharmaceutical,Group (NYSE: SCR ), a leading manufacturer ... anti-cancer biotech,product Endu in China, today announced that the Company,s ... * Brean Murray Carret & Co. All Cap China ... York on Monday, May 19, 2008 at 2:00 p.m. ET, ...
... May 14 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products Group ... on results of testing of Kiwa,s bio-fertilizer,product, ... start placing orders for,Kiwa Shandong,s products in ... Service Centre (Beijing,Olympic Vegetable Base Management Centre) ...
... Mass., May 14 Cynosure, Inc.,(Nasdaq: CYNO ... broad array of,light-based aesthetic treatment systems, today announced ... of global marketing. Lee will develop and,implement worldwide ... including the Smartlipo MPX, the company,s newest system,for ...
Other Biology Technology:Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York 2Kiwa Bio-Tech Passes Test & Taking Orders From Beijing Lv Fu Long Vegetable Company 2Cynosure Appoints H. Travis Lee as Vice President of Global Marketing 2Cynosure Appoints H. Travis Lee as Vice President of Global Marketing 3
(Date:12/15/2009)... look forward to ultra-low powered or self powered ... phones. This is made possible with power management ... elements for power optimisation and higher energy efficiency ... design is the key enabling capability for power ... in advanced analog and mixed signal design capabilities, ...
(Date:12/14/2009)... -- Researchers at Rice University and Baylor College of ... be tracked in real time with MRI as it ... fluorescent dye and kills them with heat. The all-in-one ... growing field called "theranostics" that develops technologies physicians can ... procedure. , The research is available online in the ...
(Date:12/14/2009)... date of the proteins in a species of salamander ... how similar regeneration could be induced in humans. ... University-Purdue University Indianapolis and colleagues investigated over three hundred ... of salamander that has the unique natural ability to ... hope that this knowledge will contribute to a better ...
Breaking Biology News(10 mins):NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Tracking new cancer-killing particles with MRI 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2CSCs Identity Management and Biometric Test Lab Achieves ISO IEC 17025 Accreditation 11046 1CSCs Identity Management and Biometric Test Lab Achieves ISO IEC 17025 Accreditation 11046 2New InSiteRx 26amp 3B 238482 3B Remote Dispensing Technology Automates Pharmacy Functions in Long Term Care Market 62927 1New InSiteRx 26amp 3B 238482 3B Remote Dispensing Technology Automates Pharmacy Functions in Long Term Care Market 62927 2SAS 70 Data Centers Help Protect Against Data Breaches 62925 1SAS 70 Data Centers Help Protect Against Data Breaches 62925 2SAS 70 Data Centers Help Protect Against Data Breaches 62925 3
... that elevated allergen levels in the home are associated ... that asthmatics that have allergies may alleviate symptoms by ... carried out by researchers at the National Institute of ... Inc., and the Constella Group. The teams findings may ...
... Cambridge, MA February 29, 2008 SPARC (the ... the Association of Research Libraries (ARL) have jointly released ... administrators ensure their institutions comply with public access requirements ... Institutes of Health (NIH) funding. , Effective April 7, ...
... Arizona University has released a report that identifies the ... 2 million acres of Arizona forests, representing the first ... issue of forest thinning. , The Wood Supply Analysis ... million cubic feet of wood and 8 million tons ...
Other Biology News:Increased allergen levels in homes linked to asthma 2New whitepaper offers options for university implementation of NIH policy 2Stakeholders use science to find common ground on wood supply from forests 2Stakeholders use science to find common ground on wood supply from forests 3
... R.A.P.I.D. System (Ruggedized Advanced Pathogen Identification ... thermocycler designed for field hospitals, mobile ... addition to its ruggedness, it is ... specify as the LightCycler instrument. By ...
... Library Panels were designed for full-length gene ... PCRs to identify the desired cDNA clone. ... a 96-well "Master Plate," where each well ... identified the positive well(s) by gel electrophoresis ...
... Analysis Note: Evaluated for its amino acid acceptor ... amino acids Ala, Asp, Gly, Ile, Lys, Pro, ... Tyr. Preparation Unit Definition: One unit will yield ... ml of water (1 cm light path). ...
... instrument for calibrating single-channel and multi-channel pipettes. ... robust carrying case, the MCP1-S is ideal ... and on-site at the users premises. The ... the individual channels are tested automatically. Multi-channel ...
Biology Products: